Ables Iannone Moore & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3
Closed -$812 162
2023
Q4
$812 Buy
+3
New +$741 ﹤0.01% 259

Other funds holding HCA

Ables Iannone Moore & Associates's HCA Position: Q1 2024 in Review

Ables Iannone Moore & Associates sold out of HCA Healthcare (HCA) in Q1 2024, closing a stake of 3 shares — an estimated $812 sold.

Ables Iannone Moore & Associates first reported a position in HCA in Q4 2023 and held it in 1 quarter. The position peaked at $812 in Q4 2023. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.

  • Ables Iannone Moore & Associates reported no remaining HCA Healthcare position as of Q1 2024 after selling out during the quarter.
  • Ables Iannone Moore & Associates sold 3 HCA Healthcare shares in Q1 2024, an estimated $812.
  • Ables Iannone Moore & Associates first reported a position in HCA Healthcare in Q4 2023 and held it in 1 quarter.
  • Ables Iannone Moore & Associates's HCA Healthcare position peaked at $812 in Q4 2023.
  • 1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.

Based on Ables Iannone Moore & Associates's 13F filing for Q1 2024, filed 30 Apr 2024.